Respiratory Medicine
Volume 104, Issue 7 , Pages 1027-1034 , July 2010

The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients

  • Luciana Paladini

      Affiliations

    • Department of Geriatry, University Campus Bio-Medico, Rome, Italy
    • Corresponding Author InformationCorresponding author. Dipartimento di Geriatria, Università Campus Bio-medico, via Alvaro del Portillo 21, 00128, Rome, Italy. Tel.: +39 06225411167.
    • ,
  • Rick Hodder

      Affiliations

    • Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    • ,
  • Isabella Cecchini

      Affiliations

    • HealthCare Department of Medicine, GFK Eurisko, Milan, Italy
    • ,
  • Vincenzo Bellia

      Affiliations

    • Department of Medicine, Pneumology, Physiology and Nutrition, University of Palermo, Palermo, Italy
    • ,
  • Raffaele Antonelli Incalzi

      Affiliations

    • Department of Geriatry, University Campus Bio-Medico, Rome, Italy

Received 2 August 2009 ,Accepted 29 December 2009.

References 

  1. Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD. 2005;2(2):277–283
  2. Global initiative for chronic obstructive lung disease. Guidelines: workshop report; global strategy for diagnosis, management, and prevention of COPD, updated; November 2008.
  3. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946
  4. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow obstruction. Am Rev Respir Dis. 1992;146:935–940
  5. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Int Med. 1997;127:1072–1079
  6. Curtis J, Deyo R, Hudson L. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax. 1994;49:162–170
  7. Partridge M. Living with COPD: the patients' perspective. Eur Respir Rev. 2004;1–5
  8. Jenkins C, Rodriquez-Roisin R. Quality of life, stage severity and COPD. Eur Respir J. 2009;33:953–955
  9. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56:880–887
  10. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol. 1999;52:187–192
  11. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St George respiratory questionnaire. Am Rev Respir Dis. 1992;145:1321–1327
  12. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778
  13. Tsai C, Hodder R, Page J, et al. The short-form chronic respiratory disease questionnaire was a valid, reliable, and responsive quality-of-life instrument in acute exacerbations of chronic obstructive pulmonary disease. J Clin Epidemiol. 2008;61:489–497
  14. Fletcher CM, Elmes PC, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ. 1959;2:257–266
  15. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85:751–758
  16. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:785–790
  17. Oga T, Nishimura K, Tsukino M, et al. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Resp Med. 2007;101(1):146–153
  18. Miravitlles M, Llor C, de Castellar R, et al. Validation of the COPD severity score for use in primary care: the NEREA study. Eur Respir J. 2009;33:519
  19. Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med. 2009;103(7):1070–1075
  20. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012
  21. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–1440
  22. Hernández MT, Rubio TM, Ruiz FO, Riera HS, Gil RS, Gómez JC. Results of a home-based training program for patients with COPD. Chest. 2000;118:106–114
  23. Akamatsu K, Yamagata T, Takahashi T, et al. Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist. Pulm Pharmacol Ther. 2007;20(6):701–707
  24. De Torres JP, Pinto-Plata V, Ingenito E, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121:1092–1098
  25. Kardos P, Wencker M, Glaab T, Vogelmeier C. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:144–149
  26. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the medical research council dyspnoea scale as a measure of disability in patients with COPD. Thorax. 1999;54:581–586
  27. O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian thoracic society recommendations for management of chronic obstructive pulmonary disease–2007 update. Can Respir J. 2007;14:5B
  28. Riegel B, Carlson B, Kopp Z, LePetri B, Glaser D, Unger A. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med. 2002;162:705–712
  29. Austin JS, Maisiak RS, Macrina DM, Heck LW. Health outcome improvements in patients with systemic lupus erythematosus using two telephone counseling interventions. Arthritis Care Res. 1996;9:391–399
  30. Mohr DC, Likosky W, Bertagnolli A, et al. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol. 2000;68:356–361
  31. Simon GE, VonKorff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320:550–554
  32. Piette JD, Weinberger M, McPhee SJ. The effect of automated calls with telephone nurse follow-up on patient-centered outcomes of diabetes care: a randomized, controlled trial. Med Care. 2000;38:218–230
  33. Barr RG, Celli BR, Mannino DM, et al. Comorbidities, patient knowledge and disease management in a national sample of patients with COPD. Am J Med. 2009;122(4):348–355
  34. Eisner M, Trupin L, Katz P, et al. Development and validation of a survey-based COPD severity score. Chest. 2005;127(6):1890–1897
  35. Miravitlles M, de la Roza C, Morera J, et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med. 2006;100(11):1973–1980
  36. Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006;130(6):1844–1850
  37. Hernandez P, Balter M, Bourbeau J, Hodder R. Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes. Respir Med. 2009;103(7):1004–1012
  38. Huijnen B, Van Der Horst F, van Amelsvoort L, et al. Dyspnoea in elderly family practice patients. Occurrence, severity, quality of life and mortality over an 8-year period. Fam Pract. 2006;23(1):34–39
  39. Ho SF, O'Mahony MS, Steward JA, Breay P, Buchalter M, Burr ML. Dyspnoea and quality of life in older people at home. Age and Ageing. 2001;30(2):155–159
  40. Rennard S, Decramer M, Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: Subjects' perspective of confronting COPD International survey. Eur Respir J. 2002;20:799–805
  41. Appleton S, Adams R, Porter S, Peacock M, Ruffin R. Sustained improvements in dyspnoea and pulmonary function 3 to 5 years after lung volume reduction surgery. Chest. 2003;123:1838–1846
  42. Shinar D, Gross CR, Bronstein KS, et al. Reliability of the activities of daily living scale and its use in telephone interview. Arch Phys Med Rehabil. 1987;68(10):723–728
  43. Ciesla JR, Shi L, Stoskopf CH, Samuels ME. Reliability of kat's activities of daily living scale when used in telephone interview. Eval Health Prof. 1993;16(2):190–203
  44. Altman DG. Practical statistics for medical research. Chapman and Hall; 1991;
  45. Nikolova R, Demers R, Beland F. Trajectories of cognitive decline in functional status in the frail older adults. Arch Gerontol Geriatr. 2009;48(1):28–34
  46. Antonelli Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10:2794–2800
  47. Kanner RE, Renzetti AD, Stanish WM, Barkman HW, Klauber MR. Predictors of survival in subjects with chronic airflow limitation. Am J Med. 1983;74:249–255
  48. Anthonisen NR. Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Respir Dis. 1989;140:S95–S99
  49. Burrows B, Bloom JW, Traver GA, Cline MG. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987;317:1309–1314
  50. Schellevis FG, Van der Velden J, Van de Lisdonk E, Van Eijk JM, Van Weel C. Co-morbidity of chronic diseases in general practice. J Clin Epidemiol. 1993;46:469–473
  51. Antonelli Incalzi R, Imperiale C, Bellia V, et al. Do GOLD stages of COPD severity really correspond to difference in health status?. Eur Respir J. 2003;22(3):444–449
  52. Biskobing DM. COPD and osteoporosis. Chest. 2002;121:609–620
  53. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 2005;128:2005–2011
  54. Mannino DM. COPD: Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121:121S–126S
  55. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung health study research group. hospitalizations and mortality in the lung health study. Am J Respir Crit Care Med. 2002;166:333–339
  56. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: kaiser permanente medical care program. Chest. 2005;128:2068–2075
  57. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16:63–70
  58. Kinnunen T, Saynajakangas O, Tuuponen T, Keistinen T. Impact of comorbidities on the duration of COPD patients' hospital episodes. Respir Med. 2003;97:143–146
  59. Ward MM, Javitz HS, Smith WM, Bakst A, Orzolek WS. Cost of hospitalizations for COPD: a comparison of three approaches for attributing cost diagnosis. Abstr Book Assoc Health Serv Res Meet. 1998;15:304–305
  60. Dal Negro R, Rossi A, Cerveri I. The burden of COPD in Italy: results from the confronting COPd survey. Respir Med. 2003;97:43–50Suppl C
  61. Wouters EF. Economic analysis of the confronting COPD survey: an overview of results. Suppl C Respir Med. 2003;97:S3–S14
  62. Sweer L, Zwillich CW. Dyspnea in the patient with chronic obstructive pulmonary disease: etiology and management. Clin Chest Med. 1990;11:417–445
  63. Goldstein RS, Gort EH, Stubbing D, Avendano MA. GuyattvGH. Randomised controlled trial of respiratory rehabilitation. Lancet. 1994;344:1394–1397
  64. Niederman MS, Clemente PH, Fein AM, et al. Benefits of a multidisciplinary pulmonary rehabilitation program. Chest. 1991;99(4):798–804
  65. Zu Wallack RL, Patel K, Reardon JZ, Clark BA, Normandin EA. Predictors of improvement in the 12-minute walking distance following a six-week outpatients pulmonary rehabilitation program. Chest. 1991;99:805–808
  66. Maltais F, Le Blanc P, Jobin J, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155(2):555–561
  67. Restrick LJ, Paul EA, Braid GM, Cullinan P, Moore-Gillon J, Wedzicha JA. Assessment and follow up of patients prescribed long term oxygen therapy. Thorax. 1993;48:708–713

PII: S0954-6111(10)00002-8

doi: 10.1016/j.rmed.2009.12.012

Respiratory Medicine
Volume 104, Issue 7 , Pages 1027-1034 , July 2010

Article Tools

* Image Usage & Resolution